This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy? [Yahoo! Finance]
Should You Buy Vertex Pharmaceuticals on the Dip Before Potentially Enormous News in January 2025? [Yahoo! Finance]
1 big new Green Flag for CRISPR Therapeutics' Stock [Yahoo! Finance]
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $86.00 price target on the stock.
Capsida Biotherapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]